Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs051180044Completed
Open-label, single-arm trial of indocyanine green in cancer. Primary endpoints: Safety of intravenous indocyanine green and Intraoperative fluorescence detection of pulmonary metastases. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs051180044.